Orexigen Therapeutics (OREX), maker of the weightloss drug candidate Contrave, are awaiting FDA approval for the third newest diet pill likely to be approved. Contrave is the third prescription diet drug candidate to face the FDA’s advisory panel this year,…
Get help in selecting top diet and health aides on the market
